Therefore, one of the goals of the medical community should be to identify and evaluate the behavioral factors that may be contributing to PCOS not only in order to ameliorate the burden on the healthcare system as a whole but also to proactively decrease the long-term health risks in fetal programming that can arise from disruption in the insulin-IGF-1 signaling. The gene discussed is IGF1; the disease is polycystic ovary syndrome.